134 related articles for article (PubMed ID: 34592904)
1. Exploring anti-liver cancer targets and mechanisms of oxyresveratrol:
Zhao F; Qin J; Liang Y; Zhou R
Bioengineered; 2021 Dec; 12(2):9939-9948. PubMed ID: 34592904
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses.
Li R; Song Y; Ji Z; Li L; Zhou L
Biofactors; 2020 Jan; 46(1):158-167. PubMed ID: 31647596
[TBL] [Abstract][Full Text] [Related]
3. Oxyresveratrol Is a Phytoestrogen Exerting Anti-inflammatory Effects Through NF-κB and Estrogen Receptor Signaling.
Wei J; Chen JR; Pais EMA; Wang TY; Miao L; Li L; Li LY; Qiu F; Hu LM; Gao XM; Fan GW
Inflammation; 2017 Aug; 40(4):1285-1296. PubMed ID: 28484893
[TBL] [Abstract][Full Text] [Related]
4. Oxyresveratrol abrogates oxidative stress by activating ERK-Nrf2 pathway in the liver.
Choi HY; Lee JH; Jegal KH; Cho IJ; Kim YW; Kim SC
Chem Biol Interact; 2016 Feb; 245():110-21. PubMed ID: 26102008
[TBL] [Abstract][Full Text] [Related]
5. Oxyresveratrol prevents murine H22 hepatocellular carcinoma growth and lymph node metastasis via inhibiting tumor angiogenesis and lymphangiogenesis.
Liu Y; Ren W; Bai Y; Wan L; Sun X; Liu Y; Xiong W; Zhang YY; Zhou L
J Nat Med; 2018 Mar; 72(2):481-492. PubMed ID: 29350326
[TBL] [Abstract][Full Text] [Related]
6. A comparative study on the effects of resveratrol and oxyresveratrol against tyrosinase activity and their inhibitory mechanism.
Zeng HJ; Li QY; Ma J; Yang R; Qu LB
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Apr; 251():119405. PubMed ID: 33450449
[TBL] [Abstract][Full Text] [Related]
7. Genistein exerts anti-colorectal cancer actions: clinical reports, computational and validated findings.
Liu X; Lan Y; Zhang L; Ye X; Shen Q; Mo G; Chen X
Aging (Albany NY); 2023 May; 15(9):3678-3689. PubMed ID: 37155147
[TBL] [Abstract][Full Text] [Related]
8. Oxyresveratrol ameliorates ethanol-induced gastric ulcer via downregulation of IL-6, TNF-α, NF-ĸB, and COX-2 levels, and upregulation of TFF-2 levels.
Aziz RS; Siddiqua A; Shahzad M; Shabbir A; Naseem N
Biomed Pharmacother; 2019 Feb; 110():554-560. PubMed ID: 30530291
[TBL] [Abstract][Full Text] [Related]
9. The anti-biofilm and anti-virulence activities of
Lee JH; Kim YG; Raorane CJ; Ryu SY; Shim JJ; Lee J
Biofouling; 2019 Aug; 35(7):758-767. PubMed ID: 31505984
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer.
Yuan C; Wang MH; Wang F; Chen PY; Ke XG; Yu B; Yang YF; You PT; Wu HZ
Life Sci; 2021 Apr; 270():119105. PubMed ID: 33497736
[TBL] [Abstract][Full Text] [Related]
11. A network pharmacology strategy to investigate the anti-osteoarthritis mechanism of main lignans components of Schisandrae Fructus.
Min L; Wu Y; Cao G; Mi D; Chen C
Int Immunopharmacol; 2021 Sep; 98():107873. PubMed ID: 34182246
[TBL] [Abstract][Full Text] [Related]
12. In-vitro and in-vivo anti-inflammatory effect of oxyresveratrol from Morus alba L.
Chung KO; Kim BY; Lee MH; Kim YR; Chung HY; Park JH; Moon JO
J Pharm Pharmacol; 2003 Dec; 55(12):1695-700. PubMed ID: 14738598
[TBL] [Abstract][Full Text] [Related]
13. Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
Jia YN; Lu HP; Peng YL; Zhang BS; Gong XB; Su J; Zhou Y; Pan MH; Xu L
Int Immunopharmacol; 2018 Mar; 56():105-112. PubMed ID: 29414639
[TBL] [Abstract][Full Text] [Related]
14. Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments.
Yu S; Gao W; Zeng P; Chen C; Zhang Z; Liu Z; Liu J
Biomed Pharmacother; 2021 Jul; 139():111612. PubMed ID: 33915505
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice.
Zhao RL; He YM
J Ethnopharmacol; 2018 Jan; 210():287-295. PubMed ID: 28882624
[TBL] [Abstract][Full Text] [Related]
16. Effects of resveratrol, oxyresveratrol, and their acetylated derivatives on cellular melanogenesis.
Park J; Park JH; Suh HJ; Lee IC; Koh J; Boo YC
Arch Dermatol Res; 2014 Jul; 306(5):475-87. PubMed ID: 24414332
[TBL] [Abstract][Full Text] [Related]
17. A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC).
Shen HY; Li XQ; Fan WQ; Wang YW; Huang F; Wu JQ; Zhang W; Feng XS; Chao X
Eur J Pharmacol; 2021 Oct; 909():174405. PubMed ID: 34384755
[TBL] [Abstract][Full Text] [Related]
18. A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling.
Yang AL; Wu Q; Hu ZD; Wang SP; Tao YF; Wang AM; Sun YX; Li XL; Dai L; Zhang J
Toxicol Appl Pharmacol; 2021 Nov; 431():115739. PubMed ID: 34619160
[TBL] [Abstract][Full Text] [Related]
19. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
[TBL] [Abstract][Full Text] [Related]
20. Oxyresveratrol: Sources, Productions, Biological Activities, Pharmacokinetics, and Delivery Systems.
Likhitwitayawuid K
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
